Skip to content

RYFNAHHSUMINCC-UHFFFAOYSA-N

C27H30F2N4O4 — CID 126688629

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC3-(difluoromethyl)-N-[1-[1-(2-hydroxyethyl)cyclohexyl]-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide
SMILESO=C(Nc1nc2cc(N3CCOCC3=O)ccc2n1C1(CCO)CCCCC1)c1cccc(C(F)F)c1
InChIInChI=1S/C27H30F2N4O4/c28-24(29)18-5-4-6-19(15-18)25(36)31-26-30-21-16-20(32-12-14-37-17-23(32)35)7-8-22(21)33(26)27(11-13-34)9-2-1-3-10-27/h4-8,15-16,24,34H,1-3,9-14,17H2,(H,30,31,36)
InChIKeyRYFNAHHSUMINCC-UHFFFAOYSA-N
MW512.56 g/mol
LogP4.63
Rot. Bonds7

About RYFNAHHSUMINCC-UHFFFAOYSA-N

RYFNAHHSUMINCC-UHFFFAOYSA-N (PubChem CID 126688629) has the molecular formula C27H30F2N4O4 and a molecular weight of 512.56 g/mol. Its IUPAC name is 3-(difluoromethyl)-N-[1-[1-(2-hydroxyethyl)cyclohexyl]-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide.

Molecular Properties

Compound NameRYFNAHHSUMINCC-UHFFFAOYSA-N
PubChem CID126688629
Molecular FormulaC27H30F2N4O4
Molecular Weight512.56 g/mol
Exact Mass512.22
IUPAC Name3-(difluoromethyl)-N-[1-[1-(2-hydroxyethyl)cyclohexyl]-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide
SMILESO=C(Nc1nc2cc(N3CCOCC3=O)ccc2n1C1(CCO)CCCCC1)c1cccc(C(F)F)c1
InChIInChI=1S/C27H30F2N4O4/c28-24(29)18-5-4-6-19(15-18)25(36)31-26-30-21-16-20(32-12-14-37-17-23(32)35)7-8-22(21)33(26)27(11-13-34)9-2-1-3-10-27/h4-8,15-16,24,34H,1-3,9-14,17H2,(H,30,31,36)
InChIKeyRYFNAHHSUMINCC-UHFFFAOYSA-N
XLogP4.63
TPSA96.69 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms37
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500512.56
LogP ≤ 54.63
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze RYFNAHHSUMINCC-UHFFFAOYSA-N with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of RYFNAHHSUMINCC-UHFFFAOYSA-N?
The IUPAC name of RYFNAHHSUMINCC-UHFFFAOYSA-N (CID 126688629) is 3-(difluoromethyl)-N-[1-[1-(2-hydroxyethyl)cyclohexyl]-5-(3-oxomorpholin-4-yl)benzimidazol-2-yl]benzamide.
What is the SMILES notation for RYFNAHHSUMINCC-UHFFFAOYSA-N?
The canonical SMILES for RYFNAHHSUMINCC-UHFFFAOYSA-N is O=C(Nc1nc2cc(N3CCOCC3=O)ccc2n1C1(CCO)CCCCC1)c1cccc(C(F)F)c1.
What is the InChIKey of RYFNAHHSUMINCC-UHFFFAOYSA-N?
The InChIKey is RYFNAHHSUMINCC-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H30F2N4O4/c28-24(29)18-5-4-6-19(15-18)25(36)31-26-30-21-16-20(32-12-14-37-17-23(32)35)7-8-22(21)33(26)27(11-13-34)9-2-1-3-10-27/h4-8,15-16,24,34H,1-3,9-14,17H2,(H,30,31,36).
What are the key properties of RYFNAHHSUMINCC-UHFFFAOYSA-N?
RYFNAHHSUMINCC-UHFFFAOYSA-N has a molecular weight of 512.56 g/mol, XLogP of 4.63, 7 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for RYFNAHHSUMINCC-UHFFFAOYSA-N is sourced from PubChem (CID 126688629), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.